These results confirm that miR-597-5p is an inhibitor of metastatic progression of CRC and its downregulation promotes CRC metastasis, and that this effect is mediated by miR-597-5p-mediated regulation of FOSL2 protein expression. This evidence concerns the gene FOSL2 and colorectal carcinoma.